{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T05:57:28Z","timestamp":1768456648120,"version":"3.49.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Research on Emerging and Re-emerging Infectious Diseases, or Intractable Inflammatory Bowel Disease, Health and Labor Sciences Research Grants, Health and Labor Sciences Research Grants"},{"name":"Health and Labor Sciences Research Grants for Research"},{"name":"Ministry of Health, Labor and Welfare, Japan"}],"content-domain":{"domain":["ecco-jccjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Crohn's and Colitis"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.crohns.2013.08.008","type":"journal-article","created":{"date-parts":[[2013,9,5]],"date-time":"2013-09-05T01:31:06Z","timestamp":1378344666000},"page":"223-233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Infliximab and\/or immunomodulators inhibit immune responses to trivalent influenza vaccination in adults with inflammatory bowel disease"],"prefix":"10.1093","volume":"8","author":[{"given":"Yoshie","family":"Hagihara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoko","family":"Ohfuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Yamagami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wakaba","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Kamata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsue","family":"Sogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatsugu","family":"Shiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Tanigawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunari","family":"Tominaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuo","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"issue":"7","key":"10.1016\/j.crohns.2013.08.008_bb0005","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/01.MIB.0000225332.83861.5f","article-title":"Functional consequences of NOD2(CARD15) mutations","volume":"12","author":"Abraham","year":"2006","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"10.1016\/j.crohns.2013.08.008_bb0010","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/01.MIB.0000160742.91602.b7","article-title":"Methods to avoid infections in patients with inflammatory bowel disease","volume":"11","author":"Aberra","year":"2005","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"10.1016\/j.crohns.2013.08.008_bb0015","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.cgh.2006.03.002","article-title":"Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry","volume":"4","author":"Lichtenstein","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.crohns.2013.08.008_bb0020","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/gut.2006.114660","article-title":"Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis","volume":"57","author":"Viget","year":"2008","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.crohns.2013.08.008_bb0025","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1053\/j.gastro.2008.01.012","article-title":"Risk factors for opportunistic infections in patients with inflammatory bowel disease","volume":"134","author":"Toruner","year":"2008","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.crohns.2013.08.008_bb0030","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1111\/j.1572-0241.2004.41389_7.x","article-title":"Disseminated primary varicella after initiation of infliximab for Crohn's disease","volume":"99","author":"Leung","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.crohns.2013.08.008_bb0035","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/00005176-199504000-00016","article-title":"Overwhelming varicella pneumonia in a patient with Crohn's disease treated with 6-mercaptopurine","volume":"20","author":"Deutsch","year":"1995","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"9","key":"10.1016\/j.crohns.2013.08.008_bb0040","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/gut.2004.040675","article-title":"Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis","volume":"53","author":"Esteve","year":"2004","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.crohns.2013.08.008_bb0045","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/ajg.2009.733","article-title":"A practical guide to vaccinating the inflammatory bowel disease patient","volume":"105","author":"Wasan","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.crohns.2013.08.008_bb0050","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/ibd.20943","article-title":"Vaccination strategies for patients with inflammatory bowel disease on immunomodulators and biologics","volume":"15","author":"Melmed","year":"2009","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.crohns.2013.08.008_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1750-2659.2008.00035.x","article-title":"Role of influenza and other respiratory viruses in admissions of adults to Canadian hospitals","volume":"2","author":"Schanzer","year":"2008","journal-title":"Influenza Other Respi Viruses"},{"issue":"2","key":"10.1016\/j.crohns.2013.08.008_bb0060","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.crohns.2013.08.008_bb0065","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/jama.292.11.1333","article-title":"Influenza-associated hospitalizations in the United States","volume":"292","author":"Thompson","year":"2004","journal-title":"JAMA"},{"issue":"25","key":"10.1016\/j.crohns.2013.08.008_bb0070","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1056\/NEJMoa0903810","article-title":"Emergence of a novel swine-origin influenza A(H1N1) virus in humans","volume":"360","author":"Dawood","year":"2009","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.crohns.2013.08.008_bb0075","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1056\/NEJMoa0906695","article-title":"Hospitalized patients with 2009 H1N1 influenza in the United States, April\u2013June 2009","volume":"361","author":"Jain","year":"2009","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.crohns.2013.08.008_bb0080","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ibd.21706","article-title":"Immunogenicity and safety of influenza vaccination in children with bowel disease","volume":"18","author":"deBruyn","year":"2012","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.crohns.2013.08.008_bb0085","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/gutjnl-2011-300256","article-title":"Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease","volume":"61","author":"Cullen","year":"2012","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.crohns.2013.08.008_bb0090","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.crohns.2012.05.011","article-title":"Immune response to influenza A\/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-\u03b1 agents: effects of combined therapy with immunosuppressants","volume":"7","author":"Andrisani","year":"2013","journal-title":"J Crohns Colitis"},{"issue":"2","key":"10.1016\/j.crohns.2013.08.008_bb0095","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.crohns.2011.12.004","article-title":"Long term safety and efficacy of H1N1 vaccine in a single-center cohort of IBD patients treated with immunomodulators and\/or anti-TNF\u03b1 biologics","volume":"6","author":"Kyriakos","year":"2012","journal-title":"J Crohns Colitis"},{"issue":"4","key":"10.1016\/j.crohns.2013.08.008_bb0100","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/gut.2010.233981","article-title":"H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapy","volume":"60","author":"Rahier","year":"2011","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.crohns.2013.08.008_bb0105","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/ibd.20731","article-title":"Influenza vaccinations: should they really be encouraged for IBD patients being treated with immunosuppressives?","volume":"15","author":"Fields","year":"2009","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"10.1016\/j.crohns.2013.08.008_bb0110","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.cgh.2007.02.035","article-title":"Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease","volume":"5","author":"Mamula","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.crohns.2013.08.008_bb0115","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.crohns.2012.06.019","article-title":"Incidence and characteristics of the 2009 influenza (H1N1) infections in inflammatory bowel disease patients","volume":"7","author":"Naganuma","year":"2013","journal-title":"J Crohns Colitis"},{"issue":"2","key":"10.1016\/j.crohns.2013.08.008_bb0120","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ajg.2008.120","article-title":"Immune response to influenza vaccine in children with inflammatory bowel disease","volume":"104","author":"Lu","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.crohns.2013.08.008_bb0125","series-title":"Note for guidance on harmonisation of requirements for influenza vaccines (CPMP\/BWP\/214\/96)","article-title":"European Committee for Proprietary Medical Products","year":"1997"},{"issue":"6666","key":"10.1016\/j.crohns.2013.08.008_bb0130","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/bmj.298.6666.82","article-title":"Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial","volume":"298","author":"Rachmilewitz","year":"1989","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.crohns.2013.08.008_bb0135","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn's disease activity index. National cooperative Crohn's disease study","volume":"70","author":"Best","year":"1976","journal-title":"Gastroenterology"},{"issue":"4 Pt 2","key":"10.1016\/j.crohns.2013.08.008_bb0140","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0016-5085(79)90384-6","article-title":"Rederived values of the eight coefficients of the Crohn's disease activity index (CDAI)","volume":"77","author":"Best","year":"1979","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.crohns.2013.08.008_bb0145","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/infdis\/jir026","article-title":"Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine among pregnant women: lowered antibody response by prior seasonal vaccination","volume":"203","author":"Ohfuji","year":"2011","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.crohns.2013.08.008_bb0150","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1084\/jem.75.1.49","article-title":"The quantitative determination of influenza virus and antibodies by means of red cell agglutination","volume":"75","author":"Hirst","year":"1942","journal-title":"J Exp Med"},{"key":"10.1016\/j.crohns.2013.08.008_bb0155","series-title":"Note for guidance on harmonisation of requirements for influenza vaccines","first-page":"1","article-title":"Committee for proprietary medicinal products (CPMP)","year":"1997"},{"issue":"15","key":"10.1016\/j.crohns.2013.08.008_bb0160","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa0904492","article-title":"Infliximab, azathioprine, or combination therapy for Crohn's disease","volume":"362","author":"Colombel","year":"2010","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.crohns.2013.08.008_bb0165","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/j.1572-0241.2006.00646.x","article-title":"Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses","volume":"101","author":"Melmed","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.crohns.2013.08.008_bb0170","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1002\/ibd.21667","article-title":"Vaccinating the inflammatory bowel disease patient: deficiencies in gastroenterologist's knowledge","volume":"17","author":"Wasan","year":"2011","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"10.1016\/j.crohns.2013.08.008_bb0175","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00054725-200409000-00028","article-title":"Guidelines for immunizations in patients with inflammatory bowel disease","volume":"10","author":"Sands","year":"2004","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"10.1016\/j.crohns.2013.08.008_bb0180","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1155\/2012\/158362","article-title":"An audit of influenza vaccination status in adults with inflammatory bowel disease","volume":"26","author":"Narula","year":"2012","journal-title":"Can J Gastroenterol"},{"issue":"8","key":"10.1016\/j.crohns.2013.08.008_bb0185","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1473-3099(09)70175-6","article-title":"Influenza in immunosuppressed populations: A review of infection frequency, morbidity, mortality, and vaccine responses","volume":"9","author":"Kunisaki","year":"2009","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.crohns.2013.08.008_bb0190","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/ibd.21688","article-title":"Normal response to vaccines in inflammatory bowel disease patients treated with thiopurines","volume":"18","author":"Dotan","year":"2012","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"10.1016\/j.crohns.2013.08.008_bb0195","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1093\/rheumatology\/kes202","article-title":"TNF blockers show distinct patterns of immune response to the pandemic influenza A H1N1 vaccine in inflammatory arthritis patients","volume":"51","author":"Fran\u00e7a","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.crohns.2013.08.008_bb0200","first-page":"CR433","article-title":"Immunization against influenza during the 2005\/2006 epidemic season and the humoral response in children with diagnosed inflammatory bowel disease (IBD)","volume":"16","author":"Romanowska","year":"2010","journal-title":"Med Sci Monit"},{"issue":"6","key":"10.1016\/j.crohns.2013.08.008_bb0205","doi-asserted-by":"crossref","first-page":"R209","DOI":"10.1186\/ar3542","article-title":"Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor","volume":"13","author":"Kobie","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.crohns.2013.08.008_bb0210","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/ibd.21800","article-title":"Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study","volume":"18","author":"Fiorino","year":"2012","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.crohns.2013.08.008_bb0215","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/ajg.2011.295","article-title":"Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab","volume":"107","author":"Moses","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.crohns.2013.08.008_bb0220","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1136\/ard.2011.152983","article-title":"Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice","volume":"70","author":"Ribeiro","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.crohns.2013.08.008_bb0225","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1136\/ard.2011.150250","article-title":"Immunogenicity and safety of the 2009 non-adjuvanted influenza A\/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases","volume":"70","author":"Saad","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.crohns.2013.08.008_bb0230","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1159\/000228576","article-title":"How do we manage vaccinations in patients with inflammatory bowel disease?","volume":"27","author":"Esteve Comas","year":"2009","journal-title":"Dig Dis"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994613002791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994613002791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/8\/3\/223\/1411654\/8-3-223.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T06:37:43Z","timestamp":1563863863000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-lookup\/doi\/10.1016\/j.crohns.2013.08.008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S1873994613002791"],"URL":"https:\/\/doi.org\/10.1016\/j.crohns.2013.08.008","relation":{},"ISSN":["1873-9946"],"issn-type":[{"value":"1873-9946","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infliximab and\/or immunomodulators inhibit immune responses to trivalent influenza vaccination in adults with inflammatory bowel disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Crohn's and Colitis","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.crohns.2013.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}